Expertise in
43
conditions

Dr. Sepideh Mokhtari

Neurology
Moffitt Cancer Center, Magnolia Campus
12902 Usf Magnolia Dr, 
Tampa, FL 
Accepting New Patients
Offers Telehealth
Expertise in
43
conditions
Moffitt Cancer Center, Magnolia Campus
12902 Usf Magnolia Dr, 
Tampa, FL 

Overview

Sepideh Mokhtari is a Neurologist practicing medicine in Tampa, Florida.

Dr. Mokhtari is highly rated in 43 conditions, according to our data. Her clinical expertise encompasses Brain Tumor, Glioma, Neurofibromatosis Type 1 (NF1), and Neurofibromatosis.

She is actively involved in clinical research, co-authoring 32 peer reviewed articles and participating in 6 clinical trials. Dr. Mokhtari is currently accepting new patients.

Specialties

Neurology

Licenses

Psychiatry & Neurology in FL

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Moffitt Cancer Center, Magnolia Campus
12902 Usf Magnolia Dr, Tampa, FL 33612

Additional Areas of Focus

Dr. Mokhtari has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients With Neurofibromatosis Type 1 (NF1)-Associated Inoperable Plexiform Neurofibromas (PNs) That Are Causing Significant Morbidity
A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients With Neurofibromatosis Type 1 (NF1)-Associated Inoperable Plexiform Neurofibromas (PNs) That Are Causing Significant Morbidity
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drug: Mirdametinib
Study Phase: Phase 2
Phase I/II Study of Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in the Management of HER2+ Breast Leptomeningeal Disease
Phase I/II Study of Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in the Management of HER2+ Breast Leptomeningeal Disease
Enrollment Status: Active_not_recruiting
Publish Date: May 26, 2026
Intervention Type: Drug, Radiation
Study Drugs: Pertuzumab, Trastuzumab
Study Phase: Phase 1/Phase 2
Phase IB Study of Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
Phase IB Study of Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
Enrollment Status: Completed
Publish Date: March 02, 2026
Intervention Type: Drug, Radiation
Study Phase: Phase 1
A Study of Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery (CED) in Patients With Suspected Recurrent/Progressive World Health Organization (WHO) Grade III or IV (High Grade) Glioma Undergoing Stereotactic Biopsy
A Study of Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery (CED) in Patients With Suspected Recurrent/Progressive World Health Organization (WHO) Grade III or IV (High Grade) Glioma Undergoing Stereotactic Biopsy
Enrollment Status: Terminated
Publish Date: May 25, 2023
Intervention Type: Drug
Study Drug: Topotecan
Study Phase: Early Phase 1
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug, Other
Study Phase: Phase 2
Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) Combined With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas
Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) Combined With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas
Enrollment Status: Completed
Publish Date: January 19, 2023
Intervention Type: Drug, Radiation
Study Drugs: Nivolumab, Bevacizumab, Ipilimumab
Study Phase: Phase 1
View 5 Less Clinical Trials

32 Total Publications

Delayed cerebral radiation necrosis after osteoradionecrosis of the skull base: a case report.
Delayed cerebral radiation necrosis after osteoradionecrosis of the skull base: a case report.
Journal: Frontiers in oncology
Published: February 20, 2026
Similar Doctors
Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

USF Health Parkinsons Disease & Movement Disorders

4001 E Fletcher Ave Fl 6, 
Tampa, FL 
 (2.4 miles away)
813-396-0751
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Hauser is a Neurologist practicing medicine in Tampa, Florida. Dr. Hauser is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, and Tardive Dyskinesia. Dr. Hauser is currently accepting new patients.

Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required

USF Health Department Of Neurology

4001 East Fletcher Avenue, 
Tampa, FL 
 (0.4 miles away)
813-821-8017
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Theresa Zesiewicz is a Neurologist practicing medicine in Tampa, Florida. Dr. Zesiewicz is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Hereditary Ataxia, Movement Disorders, Drug Induced Dyskinesia, Spinocerebellar Ataxia, and Deep Brain Stimulation. Dr. Zesiewicz is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Univ. Medical Service Association Inc.

2 Tampa General Cir, 
Tampa, FL 
 (9.1 miles away)
813-259-0965
Languages Spoken:
English, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Maxim Mokin is a Neurologist practicing medicine in Tampa, Florida. Dr. Mokin is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Stroke, Brain Aneurysm, Apoplexy, Thrombectomy, and Stent Placement. Dr. Mokin is currently accepting new patients.

Frequently Asked Questions about Dr. Sepideh Mokhtari

How do I make an appointment with Dr. Sepideh Mokhtari?

You can book an appointment with Dr. Sepideh Mokhtari by calling their office at 813-723-4721. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Sepideh Mokhtari a top-rated expert for Brain Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sepideh Mokhtari is classified as an Distinguished expert for Brain Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Sepideh Mokhtari specialize in?

While Dr. Sepideh Mokhtari is a Neurology, they have specific expertise in Brain Tumor, Glioma, and Neurofibromatosis Type 1 (NF1). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Sepideh Mokhtari participate in research or clinical trials?

Yes. Dr. Sepideh Mokhtari has published 32 articles and abstracts on conditions like Brain Tumor. You can view a list of Dr. Sepideh Mokhtari's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Sepideh Mokhtari accept my insurance?

Dr. Sepideh Mokhtari accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 813-723-4721 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mokhtari's expertise for a condition
ConditionClose
    View All 19 Distinguished Conditions
    View All 24 Advanced Conditions
    View All 84 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile